Bibliography<strong>and</strong> Segal, Sheldon (Eds.) The Antiprogestin Steroid RU <strong>486</strong> <strong>and</strong>Human Fertility Control, Plenum Press: New York: 1–27.Baulieu, Etienne-Emile. (1988a). Contragestion with RU <strong>486</strong>: A newapproach to postovulatory fertility control. Acta ObstetricaGynecologica Sc<strong>and</strong>inavica Supplement: 149:5–8.Baulieu, Etienne-Emile. (1988b). A novel approach to human fertilitycontrol: contragestion by the anti-progesterone RU <strong>486</strong>. EuropeanJournal of Gynecology <strong>and</strong> Reproductive Biology 28: 125–132.Baulieu, Etienne-Emile. (1989a). RU-<strong>486</strong> as an antiprogesterone steroid.The Journal of the American Medical Association 262:1808–1814.Baulieu, Etienne-Emile. (1989b). Contragestion <strong>and</strong> other clinicalapplications of RU <strong>486</strong>, an antiprogesterone at the receptor.Science 245:1351–1357.Berer, Marge. (1988). RU <strong>486</strong>—News <strong>and</strong> Research. Women’s GlobalNetwork for Reproductive Rights, Newsletter (Jan–Aug.): 21–22.Berer, Marge. (1989). Report of a workshop on RU <strong>486</strong>. Women’sGlobal Network for Reproductive Rights, Newsletter (April– June):2–3.Bertagna, Xavier, Bertagna, Christine, Luton, Jean-Pierre, Husson,Marc <strong>and</strong> Girard, François. (1984). The new steroid analog RU<strong>486</strong> inhibits glucocorticoid action in man. Journal of ClinicalEndocrinology <strong>and</strong> Metabolism 59:25–28.Bertagna, Xavier, Bertagna, Christine, Laudat, Marie-Helene, Husson,Jean-Marc, Girard, Francois <strong>and</strong> Luton, Jean-Pierre. (1986).Pituitary-adrenal response to the antiglucocorticoid action of RU<strong>486</strong> in Cushing’s syndrome. Journal of Clinical Endocrinology <strong>and</strong>Metabolism 63:639–643.Bischof, P., Sizonenko, M.T. <strong>and</strong> Herrmann, W.L. (1986).Trophoblastic <strong>and</strong> decidual response to RU <strong>486</strong>: effects on humanchorionic gonadotrophin, human placental lactogen, prolactin <strong>and</strong>pregnancy-associated plasma protein-A production in vitro. HumanReproduction 1:3–6.Blankenstein, M.A., Van’t Verlaat, J.W. <strong>and</strong> Croughs, R.J.M. (1989).Hormone dependency of meningiomas. The Lancet i: 1381–1382.133
RU <strong>486</strong>Bygdeman, Marc <strong>and</strong> Swahn, Marja-Liisa. (1985). Progesteronereceptor blockage: Effect on uterine contractility <strong>and</strong> earlypregnancy. Contraception 32:45–51.Bygdeman, Marc <strong>and</strong> Swahn, Marja-Liisa. (1989). Prostagl<strong>and</strong>ins <strong>and</strong>antiprogestins. Acta Obstetrica et Gynecologica Sc<strong>and</strong>inavica Supplement149:13–18.Bygdeman, Marc, Christensen, Niels <strong>and</strong> Green, Krister. (1983).Clinical experience with selected prostagl<strong>and</strong>in analogues inobstetrics <strong>and</strong> gynaecology. In: Cervagem. A new prostagl<strong>and</strong>in inobstetrics <strong>and</strong> gynaecology. Sultan M.M.Karim (Ed.), MTP Press:Lancaster, Boston, The Hague: 63–76.Cafarella, Jane (1991, 20 February). Should we swallow this pill? TheAge, Melbourne: 16.Cameron, I.T. <strong>and</strong> Baird, David, T. (1984). The use of 16,16 dimethyltrans-•2 -prostagl<strong>and</strong>in E1 methyl ester (gemeprost) vaginalpessaries for the termination of pregnancy in the early secondtrimester. A comparison with extra-amniotic prostagl<strong>and</strong>in E 2.British Journal of Obstetrics <strong>and</strong> Gynaecology 91:1136–1140.Cameron, I.T., Michie, A.F. <strong>and</strong> Baird, David T. (1986). Therapeuticabortion in early pregnancy with antiprogestogen RU <strong>486</strong> aloneor in combination with prostagl<strong>and</strong>in analogue (Gemeprost).Contraception 34: 459–469.Cameron, I.T. <strong>and</strong> Baird, David T. (1988). Early pregnancytermination: a comparison between vacuum aspiration <strong>and</strong>medical abortion using prostagl<strong>and</strong>in (16,16 dimethyl-trans-• 2 -PGE 1methyl ester) or the antiprogestogen RU <strong>486</strong>. British Journalof Obstetrics <strong>and</strong> Gynaecology 95:271–276.Caro, Denise. (1990, 23 May). Des médecins des centres d’IVGprennent la defense du RU <strong>486</strong>. Le Quotidien du Médecin No.4533:10.Cates, Willard <strong>and</strong> Jordaan, Harold V.F. (1979). Sudden collapse <strong>and</strong>death of women obtaining abortions induced with prostagl<strong>and</strong>inF 2•. American Journal of Obstetrics <strong>and</strong> Gynecology 133:398–400.Cates, Willard, Grimes, David A., Haber. Richard J. <strong>and</strong> Tyler, CarlW. (1977). Abortion deaths associated with the use of134
- Page 2 and 3:
Renate Klein is Lecturer in Women
- Page 4 and 5:
RU 486Misconceptions,Myths and Mora
- Page 6 and 7:
ACKNOWLEDGEMENTSWe would like to ex
- Page 8 and 9:
CONTENTSINTRODUCTION 1CHAPTER ONETh
- Page 10 and 11:
INTRODUCTIONInitial euphoria greete
- Page 12 and 13:
IntroductionUnfortunately, objectio
- Page 14 and 15:
Introductiondo not know or do not a
- Page 16 and 17:
Introductionused widely for years a
- Page 18 and 19:
CHAPTER ONEThe History of RU 486RU
- Page 20 and 21:
The History of RU 486consultants ar
- Page 22 and 23:
The History of RU 486Events in Fran
- Page 24 and 25:
The History of RU 486service of wom
- Page 26 and 27:
The History of RU 486The result app
- Page 28 and 29:
The History of RU 486developing cou
- Page 30 and 31:
The History of RU 486University Hos
- Page 32 and 33:
The History of RU 486pharmacovigila
- Page 34 and 35:
CHAPTER TWOClaims for RU 486/PG Abo
- Page 36 and 37:
Claims for RU 486/PG Abortionsevera
- Page 38 and 39:
Claims for RU 486/PG Abortionthe Br
- Page 40 and 41:
Claims for RU 486/PG Abortionan imm
- Page 42 and 43:
Claims for RU 486/PG Abortionby the
- Page 44 and 45:
Claims for RU 486/PG Abortionby the
- Page 46 and 47:
Claims for RU 486/PG Abortionfrom A
- Page 48 and 49:
Claims for RU 486/PG Abortioncommen
- Page 50 and 51:
Claims for RU 486/PG AbortionSome s
- Page 52 and 53:
Claims for RU 486/PG Abortionbreeze
- Page 54 and 55:
Claims for RU 486/PG Abortion18 per
- Page 56 and 57:
Claims for RU 486/PG Abortion1. RU
- Page 58 and 59:
Claims for RU 486/PG AbortionRU 486
- Page 60 and 61:
Claims for RU 486/PG Abortionwider
- Page 62 and 63:
Claims for RU 486/PG Abortionmedica
- Page 64 and 65:
Claims for RU 486/PG Abortionreligi
- Page 66 and 67:
What Is RU 486 and How Does It Work
- Page 68 and 69:
What Is RU 486 and How Does It Work
- Page 70 and 71:
What Is RU 486 and How Does It Work
- Page 72 and 73:
What Is RU 486 and How Does It Work
- Page 74 and 75:
What Is RU 486 and How Does It Work
- Page 76 and 77:
What Is RU 486 and How Does It Work
- Page 78 and 79:
What Is RU 486 and How Does It Work
- Page 80 and 81:
What Is RU 486 and How Does It Work
- Page 82 and 83:
What Is RU 486 and How Does It Work
- Page 84 and 85:
What Is RU 486 and How Does It Work
- Page 86 and 87:
What Is RU 486 and How Does It Work
- Page 88 and 89:
What Is RU 486 and How Does It Work
- Page 90 and 91:
The Role of Prostaglandins: Known a
- Page 92 and 93: The Role of Prostaglandins: Known a
- Page 94 and 95: The Role of Prostaglandins: Known a
- Page 96 and 97: The Role of Prostaglandins: Known a
- Page 98 and 99: The Role of Prostaglandins: Known a
- Page 100 and 101: The Role of Prostaglandins: Known a
- Page 102 and 103: The Role of Prostaglandins: Known a
- Page 104 and 105: The Role of Prostaglandins: Known a
- Page 106 and 107: The Role of Prostaglandins: Known a
- Page 108 and 109: The Role of Prostaglandins: Known a
- Page 110 and 111: The Role of Prostaglandins: Known a
- Page 112 and 113: The Role of Prostaglandins: Known a
- Page 114 and 115: The Role of Prostaglandins: Known a
- Page 116 and 117: The Role of Prostaglandins: Known a
- Page 118 and 119: The Role of Prostaglandins: Known a
- Page 120 and 121: The Role of Prostaglandins: Known a
- Page 122 and 123: ConclusionInstead, Baulieu uses the
- Page 124 and 125: Conclusionintervention. Thus, RU 48
- Page 126 and 127: Conclusionbetween population contro
- Page 128 and 129: ConclusionThis article, appearing i
- Page 130 and 131: Conclusion‘a whole net of relatio
- Page 132 and 133: ENDNOTESChapter One1The paten t lic
- Page 134 and 135: Endnotes12The Journal Officiel publ
- Page 136 and 137: Endnotesin Gynecology and Obstetric
- Page 138 and 139: Endnotesof menses. On the third day
- Page 140 and 141: EndnotesAnother such example is the
- Page 144 and 145: Bibliographyprostaglandin F 2•. A
- Page 146 and 147: BibliographyDelaney, Anne. (1991, 2
- Page 148 and 149: Bibliographyresponses to the steroi
- Page 150 and 151: Bibliographyabnormalities resulting
- Page 152 and 153: Bibliographyprogesterone receptor b
- Page 154 and 155: BibliographyOdlind, Viveca and Birg
- Page 156 and 157: BibliographyBinding of the anti-pro
- Page 158 and 159: BibliographyUlmann, André, Teutsch
- Page 160: Bibliographytermination by vacuum a